Empirical Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $432K | Buy |
5,528
+731
| +15% | +$59K | 0.01% | 736 |
|
|
2026
Q1 | $416K | Sell |
4,797
-2,033
| -30% | -$195K | 0.01% | 651 |
|
|
2025
Q4 | $656K | Buy |
6,830
+1,319
| +24% | +$128K | 0.01% | 432 |
|
|
2025
Q3 | $525K | Buy |
5,511
+1,230
| +29% | +$113K | 0.01% | 461 |
|
|
2025
Q2 | $373K | Sell |
4,281
-24
| -0.6% | -$2.04K | 0.01% | 476 |
|
|
2025
Q1 | $387K | Sell |
4,305
-7,309
| -63% | -$654K | 0.01% | 458 |
|
|
2024
Q4 | $928K | Buy |
11,614
+1,955
| +20% | +$169K | 0.03% | 286 |
|
|
2024
Q3 | $870K | Buy |
9,659
+718
| +8% | +$60.4K | 0.02% | 292 |
|
|
2024
Q2 | $704K | Buy |
8,941
+1,072
| +14% | +$87.9K | 0.02% | 294 |
|
|
2024
Q1 | $686K | Buy |
7,869
+2,211
| +39% | +$189K | 0.02% | 293 |
|
|
2023
Q4 | $466K | Sell |
5,658
-3,441
| -38% | -$262K | 0.02% | 332 |
|
|
2023
Q3 | $713K | Buy |
9,099
+1,651
| +22% | +$138K | 0.03% | 261 |
|
|
2023
Q2 | $656K | Buy |
7,448
+1,249
| +20% | +$108K | 0.03% | 268 |
|
|
2023
Q1 | $500K | Buy |
6,199
+43
| +0.7% | +$3.5K | 0.02% | 321 |
|
|
2022
Q4 | $478K | Sell |
6,156
-937
| -13% | -$75.9K | 0.02% | 315 |
|
|
2022
Q3 | $573K | Sell |
7,093
-3,258
| -31% | -$293K | 0.03% | 275 |
|
|
2022
Q2 | $929K | Buy |
10,351
+1,296
| +14% | +$131K | 0.05% | 206 |
|
|
2022
Q1 | $1M | Sell |
9,055
-1,087
| -11% | -$115K | 0.05% | 212 |
|
|
2021
Q4 | $1.05M | Sell |
10,142
-438
| -4% | -$50.7K | 0.05% | 209 |
|
|
2021
Q3 | $1.33M | Sell |
10,580
-144
| -1% | -$18.6K | 0.08% | 156 |
|
|
2021
Q2 | $1.33M | Sell |
10,724
-615
| -5% | -$77.2K | 0.08% | 152 |
|
|
2021
Q1 | $1.34M | Sell |
11,339
-2,278
| -17% | -$267K | 0.11% | 128 |
|
|
2020
Q4 | $1.59M | Buy |
13,617
+361
| +3% | +$39.7K | 0.12% | 115 |
|
|
2020
Q3 | $1.38M | Sell |
13,256
-440
| -3% | -$44.2K | 0.12% | 118 |
|
|
2020
Q2 | $1.26M | Buy |
13,696
+1,690
| +14% | +$162K | 0.12% | 115 |
|
|
2020
Q1 | $1.08M | Buy |
12,006
+2,434
| +25% | +$259K | 0.12% | 109 |
|
|
2019
Q4 | $1.09M | Buy |
9,572
+7,328
| +327% | +$804K | 0.12% | 118 |
|
|
2019
Q3 | $244K | Buy |
2,244
+147
| +7% | +$15.3K | 0.03% | 254 |
|
|
2019
Q2 | $204K | Buy |
+2,097
| New | +$191K | 0.03% | 249 |
|
|
2015
Q4 | – | Sell |
-4,010
| Closed | -$268K | – | 109 |
|
|
2015
Q3 | $268K | Buy |
+4,010
| New | +$295K | 0.06% | 100 |
|
Other funds holding MDT
Empirical Wealth Management's MDT Position: Q2 2026 in Review
Empirical Wealth Management increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $59K and bringing the position to 5,528 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #736.
Empirical Wealth Management first reported a position in MDT in Q3 2015 and has held it in 30 quarters since. The position peaked at $1.59M in Q4 2020. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Empirical Wealth Management held 5,528 shares of Medtronic worth $432K as of Q2 2026.
- Empirical Wealth Management bought 731 Medtronic shares in Q2 2026, an estimated $59K.
- Medtronic made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #736 holding.
- Empirical Wealth Management first reported a position in Medtronic in Q3 2015 and has held it in 30 quarters since.
- Empirical Wealth Management's Medtronic position peaked at $1.59M in Q4 2020.
- 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.